Benchmark Botanics Stock Today

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Very High

 
High
 
Low
Benchmark Botanics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Craftport Cannabis Corp. engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada. Craftport Cannabis Corp. is headquartered in Peachland, Canada. Craftport Cannabis is traded on OTC Exchange in the United States. The company has 58.99 M outstanding shares. More on Benchmark Botanics

Moving against Benchmark Pink Sheet

  0.9TAK Takeda PharmaceuticalPairCorr
  0.85VLKPF Volkswagen AG VZO Downward RallyPairCorr
  0.84VWAPY Volkswagen AG PrefPairCorr
  0.82VLKAF Volkswagen AGPairCorr
  0.81VWAGY Volkswagen AG 110PairCorr
  0.75HLN Haleon plcPairCorr
Benchmark Botanics cannot be verified against its exchange. It appears that Benchmark Botanics is not available for investing at the moment. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Refresh

Benchmark Pink Sheet Highlights

Business ConcentrationDrug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Benchmark Botanics [BHHKF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Benchmark Botanics's market, we take the total number of its shares issued and multiply it by Benchmark Botanics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Benchmark Botanics classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 58.99 M outstanding shares. Benchmark Botanics has accumulated about 273.03 K in cash with (2.73 M) of positive cash flow from operations.
Check Benchmark Botanics Probability Of Bankruptcy

Benchmark Stock Against Markets

Try Other Suggestions

B Barnes GroupCompanyDelisted
BA The BoeingCompany
BNJ Brookfield Finance 450Company
BBN Blackrock Taxable MunicipalFund
BAB Invesco Taxable MunicipalETF
BKX KBW BankIndex
BB BounceBitCryptocurrency
B5341FAB7 KBCBB 5796 19 JAN 29Corporate Bond
BZUSD Brent Crude OilCommodity

Be your own money manager

Our tools can tell you how much better you can do entering a position in Benchmark Botanics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

Benchmark Botanics Corporate Management

Claude StowellChief PotanicalsProfile
CPA CGACo ControllerProfile
Feng LuCEO CFOProfile
Yuan GaoCorp DirectorProfile
Dennis LingManaging MarketProfile

Other Information on Investing in Benchmark Pink Sheet

Benchmark Botanics financial ratios help investors to determine whether Benchmark Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Benchmark with respect to the benefits of owning Benchmark Botanics security.